# Semaglutide for Helping Opioid Recovery

> **NCT06639464** · PHASE2 · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 46 (estimated)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** Semaglutide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06639464
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-02
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2025-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06639464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06639464, "Semaglutide for Helping Opioid Recovery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06639464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*